Skip to main content

Table 1 Sociodemographic, clinical, and laboratory characteristics in 1,050 patients with clinically manifest coronary heart disease

From: Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care

Characteristics at baseline

 

Age (years) (μ, SD)

58.8 ± 8.0

Men, n (%)

892 (85.0%)

CYP2C19C*2 allele frequency

 

   - AA

27 (2.6%)

   - AG

279 (26.6%)

   - GG

744 (70.9%)

History of myocardial infarction, n (%)

611 (58.2%)

History of heart failure, n (%)

128 (12.6%)

Clinical score (angiographic evaluation)

 

   - 1 vessel disease

255 (24.3%)

   - 2 vessel disease

279 (26.6%)

   - 3 vessel disease

449 (42.8%)

   - unknown

52 (5.0%)

School education <10 yrs., n (%)

625 (59.5%)

Body mass index (kg/m2), (μ, SD)

27.1 ± 3.5

History of diabetes, n (%)

184 (17.7%)

Total cholesterol (mg/dl) (μ, SD)

168.9 (32.6)

LDL-cholesterol (mg/dl) (μ, SD)

100.4 (28.9)

HDL-cholesterol (mg/dl) (μ, SD)

39.4 (10.5)

C-reactive protein (mg/L) *

3.47 (1.23; 8.37)

Creatinine Clearance (mL/min) *

93.75 (78.20; 115.00)

Cystatin C (mg/L)*

1.03 (0.93; 1.19)

NT-proBNP (pg/mL)*

572.00 (279.90; 1101.00)

GRACE Score (points) (μ, SD)

95.9 (20.8)

  1. * median, 25th and 75th quantile cut-point.